Cargando…

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018)

BACKGROUND: The aim of this study was to develop a standardized method to reconstruct persons’ individual viral load (VL) courses to determine viral suppression and duration of viremia for the HIV care continuum in Germany using longitudinal cohort data. METHODS: We analyzed data from two large, mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Daniel, Kollan, Christian, Stoll, Matthias, Hamouda, Osamah, Bremer, Viviane, Kurth, Tobias, Bartmeyer, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825204/ https://www.ncbi.nlm.nih.gov/pubmed/33482773 http://dx.doi.org/10.1186/s12889-020-10088-7

Ejemplares similares

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013
por: Zeitlmann, Nadine, et al.
Publicado: (2016)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort
por: Stoll, Matthias, et al.
Publicado: (2011)

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort
por: Altmann, Mathias, et al.
Publicado: (2012)

Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014
por: Hofmann, Alexandra, et al.
Publicado: (2017)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study
por: zu Knyphausen, Fabia, et al.
Publicado: (2014)

Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany
por: Schmidt, Daniel, et al.
Publicado: (2014)

The denominator problem: Estimating MSM-specific incidence of sexually transmitted infections and prevalence of HIV using population sizes of MSM derived from Internet surveys
por: Marcus, Ulrich, et al.
Publicado: (2009)

Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy
por: Karo, Basel, et al.
Publicado: (2017)

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
por: Oh, Djin-Ye, et al.
Publicado: (2008)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
por: Meixenberger, Karolin, et al.
Publicado: (2017)

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
por: Schmidt, Daniel, et al.
Publicado: (2022)

HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019
por: Koppe, Uwe, et al.
Publicado: (2022)

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany
por: Schmidt, Daniel, et al.
Publicado: (2015)

High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany
por: Müller, Jana, et al.
Publicado: (2017)

Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups
por: Schenkel, Karl, et al.
Publicado: (2008)

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2020)

National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014
por: Hauser, Andrea, et al.
Publicado: (2017)

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion
por: Rüsenberg, Robin, et al.
Publicado: (2021)

Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2021)

Improved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter Cohort
por: Hauser, Andrea, et al.
Publicado: (2014)

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
por: van de Vijver, David A M C, et al.
Publicado: (2019)

Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses
por: Hauser, Andrea, et al.
Publicado: (2018)

Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005
por: Gilsdorf, Andreas, et al.
Publicado: (2010)

Factors associated with the informal use of HIV pre‐exposure prophylaxis in Germany: a cross‐sectional study
por: Koppe, Uwe, et al.
Publicado: (2019)

High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14)
por: Wenz, Benjamin, et al.
Publicado: (2016)

STI tests and proportion of positive tests in female sex workers attending local public health departments in Germany in 2010/11
por: Bremer, Viviane, et al.
Publicado: (2016)

Determinants of HIV, viral hepatitis and STI prevention needs among African migrants in Germany; a cross-sectional survey on knowledge, attitudes, behaviors and practices
por: Santos-Hövener, Claudia, et al.
Publicado: (2015)

Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease
por: Kastenbauer, U, et al.
Publicado: (2009)

Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
por: Koppe, Uwe, et al.
Publicado: (2021)

Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999–2018
por: Ismael, Nalia, et al.
Publicado: (2022)

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany
por: Jansen, Klaus, et al.
Publicado: (2015)

The impact of regional socioeconomic deprivation on the timing of HIV diagnosis: a cross-sectional study in Germany
por: Pantke, Annemarie, et al.
Publicado: (2022)

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020
por: Fiebig, Uwe, et al.
Publicado: (2023)

Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions – Cologne/Bonn, Munich and Hannover, 1999–2016
por: Stecher, Melanie, et al.
Publicado: (2018)

Development of Inflammatory Bowel Disease in HIV Patients: A Danish Cohort Study (1983–2018) With American Validation (1999–2018)
por: Elmahdi, Rahma, et al.
Publicado: (2022)

HIV molecular immunology database, 1999 /
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_1fbks70h8m2he493p8e48006pj